This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Type of economic evaluation
Cost-effectiveness analysis
Study objective
The study objective was to determine the cost-effectiveness of several screening strategies for latent tuberculosis infection in US army recruits.
Interventions
Eight screening strategies (universal, sequential and targeted) were compared with no screening. The screening strategies were a combination of universal versus targeted screening and sequential testing. Testing strategies included tuberculin skin testing versus interferon-gamma release assays. The interferon-gamma release assays included were T-SPOT and QFT (QuantiFERON-TB Gold In-Tube).
The eight strategies were: universal testing of all recruits with the tuberculosis skin test (usual practice for US military services); universal screening with T-SPOT; universal screening with QFT; sequential testing with tuberculosis skin test followed by T-SPOT assay; sequential testing with tuberculosis skin test followed by QFT assay; targeted testing with risk factor questionnaire followed by tuberculosis skin test; targeted testing with a risk factor questionnaire followed by T-SPOT assay; and targeted testing with risk factor questionnaire followed by QFT assay.
Location/setting
USA/primary care in a military setting.
Methods

Analytical approach:
A decision analytical Markov model was designed to combined published literature. Health outcomes were states of latent tuberculosis infection, previous active tuberculosis disease and death. A hypothetical cohort of 200,000 army recruits entered the model at age 20 years. The time horizon was 20 years. The authors stated that a societal perspective was adopted.
Effectiveness data:
The effectiveness data were derived from a non-published prospective study of 1979 recruits entering the US military at Fort Jackson, USA in 2009, and published studies. The main clinical effectiveness estimates were the sensitivity and specificity of the various tests.
Monetary benefit and utility valuations:
Not relevant.
